Florid Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -1.38%
- Profit Growth 254.95%
- Ebitda 15.28%
- Net Worth 25.28%
- Total Assets 63.39%
About Florid Laboratories
Florid Laboratories Private Limited (FLPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 2019 (Five years and nine months 18 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rina Kumari, Mrigank Goyal, and Prince Kumar serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U36999BR2019PTC041862
-
Company No.
041862
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Apr 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Florid Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rina Kumari
|
Whole-Time Director | 01-Apr-2020 | Current |
|
Mrigank Goyal
|
Director | 26-Apr-2019 | Current |
|
Prince Kumar
|
Director | 26-Apr-2019 | Current |
Financial Performance of Florid Laboratories.
Florid Laboratories Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.38% decrease. The company also saw a substantial improvement in profitability, with a 254.95% increase in profit. The company's net worth Soared by an impressive increase of 25.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Florid Laboratories?
In 2022, Florid Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Marina Pharmaceuticals Private LimitedRina Kumari, Mrigank Goyal and 1 more are mutual person
-
Guvnor Life Private Limited
Mrigank Goyal is a mutual person
-
Koronto Motors Private Limited
Prince Kumar is a mutual person
-
Fallonova Lifestyles Private Limited
Prince Kumar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Florid Laboratories?
Florid Laboratories has a workforce of 25 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Florid Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Florid Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.